Lupin, Sun Pharma to Cipla: Key pharma stocks that could be hit by Trump’s tariffs plan on generic medicines import

Donald Trump announced that generic drugs imported into the US will continue to attract a 0% tariff for two years from August 1. From August 2028, a 100% tariff will be imposed for one year, followed by a 200% tariff thereafter.